Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of celecoxib and optimization of intestinal sampling in healthy volunteers
2017-001194-16Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of celecoxib in colorectal cancer (CRC), sponsored by KU Leuven. Primary endpoint: Optimization of enema frequency and volume for left hemicolon cleansing. Started Oct 2017; status: completed.
02
Drugs
celecoxib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2017-001194-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001194-16.